alanine has been researched along with Carcinoma 256, Walker in 14 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The protective effects of betamipron (BP, N-benzoyl-beta-alanine) on the nephrotoxicity of cisplatin were examined as indicated by body weight gain, ratio of kidney weight to body weight, blood urea nitrogen and serum creatinine levels in tumor-bearing rats." | 3.69 | Effects of betamipron on cisplatin nephrotoxicity and its pharmacokinetics in rats. ( Arimori, K; Kitagawa, A; Kobayashi, M; Nakamura, C; Nakano, M; Tokunaga, J, 1997) |
| "The role of glutathione in the biological effects of cyclophosphamide (CP) was evaluated by investigating the following: effect of CP on hepatic glutathione levels; relationship between hepatic glutathione depletion (repletion) and the binding of [chloroethyl-3H]CP and [4-14C]CP to hepatic macromolecules; effects of interaction between CP (or acrolein) and diethyl maleate (a classical glutathione depletor), and/or between CP and cysteine on the binding of labeled CP to hepatic macromolecules, on the induction of hematuria, on the content of hepatic cytochrome P-450, on weight gain in rats, on survival in mice, and on the chemotherapeutic efficacy of CP against Walker 256 carcinoma in rats." | 3.66 | Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. ( Gurtoo, HL; Hipkens, JH; Sharma, SD, 1981) |
| "Celecoxib was administered daily (5-50 mg/kg body weight) beginning at the day in which the tumour cells were inocculated." | 1.34 | Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats. ( Acco, A; Alves da Silva, MH; Batista, MR; Bracht, A; Yamamoto, NS, 2007) |
| "The urea cycle was evaluated in perfused livers isolated from cachectic tumor-bearing rats (Walker-256 tumor)." | 1.32 | The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats. ( Bracht, A; Constantin, J; Corbello Pereira, SR; da Silva, MH; Darronqui, E; Yamamoto, NS, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreira, CC | 1 |
| Cassolla, P | 1 |
| Dornellas, AP | 1 |
| de Morais, H | 1 |
| de Souza, CO | 1 |
| Borba-Murad, GR | 1 |
| Bazotte, RB | 1 |
| de Souza, HM | 1 |
| ROSEN, F | 1 |
| HARDING, HR | 1 |
| MILHOLLAND, RJ | 1 |
| NICHOL, CA | 1 |
| Corbello Pereira, SR | 1 |
| Darronqui, E | 1 |
| Constantin, J | 1 |
| da Silva, MH | 1 |
| Yamamoto, NS | 2 |
| Bracht, A | 2 |
| Acco, A | 1 |
| Alves da Silva, MH | 1 |
| Batista, MR | 1 |
| Goodlad, GA | 2 |
| Clark, CM | 2 |
| Gurtoo, HL | 1 |
| Hipkens, JH | 1 |
| Sharma, SD | 1 |
| Tokunaga, J | 1 |
| Kobayashi, M | 1 |
| Kitagawa, A | 1 |
| Nakamura, C | 1 |
| Arimori, K | 1 |
| Nakano, M | 1 |
| Ishikawa, E | 2 |
| Jaffray, E | 1 |
| Loudon, K | 1 |
| Byvoet, P | 1 |
| Yamamoto, H | 1 |
| Aikawa, T | 1 |
| Matsuaka, H | 1 |
| DeWys, WD | 2 |
| Hall, TC | 2 |
| Carruthers, C | 1 |
14 other studies available for alanine and Carcinoma 256, Walker
| Article | Year |
|---|---|
Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.
Topics: Alanine; Animals; Carcinoma 256, Walker; Cell Proliferation; Gluconeogenesis; Glucose; Glycerol; Liv | 2013 |
GLUCOCORTICOIDS AND TRANSAMINASE ACTIVITY. VI. COMPARISON OF THE ADAPTIVE INCREASES OF ALANINE- AND TYROSINE-ALPHA-KETOGLUTARATE TRANSAMINASES.
Topics: Adrenalectomy; Alanine; Alanine Transaminase; Animals; Carcinoma 256, Walker; Desoxycorticosterone; | 1963 |
The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats.
Topics: Alanine; Ammonia; Animals; Cachexia; Carcinoma 256, Walker; In Vitro Techniques; Kinetics; Liver; Ma | 2004 |
Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
Topics: Alanine; Ammonia; Animals; Arginine; Carcinoma 256, Walker; Celecoxib; Cyclooxygenase 2 Inhibitors; | 2007 |
Leucine metabolism in skeletal muscle of the tumour-bearing rat.
Topics: Alanine; Amino Acids; Ammonia; Animals; Carcinoma 256, Walker; Diaphragm; Female; Glutamine; Glycoge | 1980 |
Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
Topics: Acrolein; Alanine; Animals; Body Weight; Carcinoma 256, Walker; Cyclophosphamide; Cysteine; Female; | 1981 |
Effects of betamipron on cisplatin nephrotoxicity and its pharmacokinetics in rats.
Topics: Alanine; Animals; Antineoplastic Agents; Bile; Blood Urea Nitrogen; Body Weight; Carcinoma 256, Walk | 1997 |
The regulation of uptake and output of amino acids by rat tissues.
Topics: Adipose Tissue; Alanine; Amino Acids; Animals; Carcinoma 256, Walker; Diet; Fasting; Female; Fetus; | 1976 |
Increased liver alanine in the tumour-bearing host. Altered levels of some enzymes involved in alanine metabolism.
Topics: Alanine; Alanine Transaminase; Animals; Carcinoma 256, Walker; Cytosol; Female; Isoenzymes; Liver; M | 1990 |
Differences in turnover between histones and their acetyl N-terminal groups.
Topics: Acetates; Alanine; Animals; Carbon Isotopes; Carcinoma 256, Walker; Carcinoma, Hepatocellular; DNA; | 1968 |
Relative uptake of plasma amino acids by fetal and tumor tissues.
Topics: Alanine; Amino Acids; Animals; Carcinoma 256, Walker; Fetus; Glutamine; Iliac Vein; Rats; Umbilical | 1974 |
Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188).
Topics: Administration, Oral; Alanine; Alkalies; Animals; Antineoplastic Agents; Body Weight; Carcinoma 256, | 1973 |
Anti-tumor effect of the amino acid minosine.
Topics: Alanine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Dose-Response Relationship, Drug; Ge | 1973 |
The influence of transplantable rat mammary carcinomas on the chemical composition of the host.
Topics: Alanine; Amino Acids; Animals; Arachidonic Acids; Carcinoma 256, Walker; Chromatography, Thin Layer; | 1969 |